Huberman Mark S相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Randomized Phase II Study of 3 Months or 2 Years of Adjuvant Afatinib in Patients With Surgically Resected Stage I-III EGFR-Mutant Non-Small-Cell Lung Cancer

一项随机II期研究，评估阿法替尼辅助治疗3个月或2年对接受手术切除的I-III期EGFR突变型非小细胞肺癌患者的疗效

期刊:Jco Precision Oncology

影响因子:5.6

doi:10.1200/PO.20.00301

Neal, Joel W; Costa, Daniel B; Muzikansky, Alona; Shrager, Joseph B; Lanuti, Michael; Huang, James; Ramachandran, Kavitha J; Rangachari, Deepa; Huberman, Mark S; Piotrowska, Zofia; Kris, Mark G; Azzoli, Christopher G; Sequist, Lecia V; Chaft, Jamie E

细胞生物学

发表日期：2021

文献求助收藏

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer

帕博利珠单抗治疗方案中延长给药间隔或延迟给药与晚期非小细胞肺癌生存结局的关系

期刊:Clinical Lung Cancer

影响因子:3.3

doi:10.1016/j.cllc.2020.05.028

Sehgal, Kartik; Bulumulle, Anushi; Brody, Heather; Gill, Ritu R; Macherla, Shravanti; Qilleri, Aleksandra; McDonald, Danielle C; Cherry, Cynthia R; Shea, Meghan; Huberman, Mark S; VanderLaan, Paul A; Weiss, Glen J; Walker, Paul R; Costa, Daniel B; Rangachari, Deepa

细胞生物学

发表日期：2021

文献求助收藏

EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas

EGFR 20号外显子插入突变在临床前模型和肺腺癌中对Hsp90抑制剂表现出敏感性

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-18-1541

Jorge, Susan E; Lucena-Araujo, Antonio R; Yasuda, Hiroyuki; Piotrowska, Zofia; Oxnard, Geoffrey R; Rangachari, Deepa; Huberman, Mark S; Sequist, Lecia V; Kobayashi, Susumu S; Costa, Daniel B

发表日期：2018

文献求助收藏

Tumor biomarker testing in non-small-cell lung cancer: A decade of change

非小细胞肺癌肿瘤生物标志物检测：十年变迁

期刊:Lung Cancer

影响因子:4.4

doi:10.1016/j.lungcan.2018.01.002

VanderLaan, Paul A; Rangachari, Deepa; Majid, Adnan; Parikh, Mihir S; Gangadharan, Sidharta P; Kent, Michael S; McDonald, Danielle C; Huberman, Mark S; Kobayashi, Susumu S; Costa, Daniel B

细胞生物学

发表日期：2018

文献求助收藏

Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy

克唑替尼作为初始精准治疗，ALK重排肺癌患者5年无进展生存期病例报告

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1016/j.jtho.2017.06.002

Rangachari, Deepa; Le, Xiuning; Shea, Meghan; Huberman, Mark S; VanderLaan, Paul A; Kobayashi, Susumu S; Costa, Daniel B

发表日期：2017

文献求助收藏

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma

EGFR、ALK 或 ROS1 经典驱动癌基因突变与肺腺癌中 22C3-PD-L1 ≥50% 表达的相关性

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1016/j.jtho.2016.12.026

Rangachari, Deepa; VanderLaan, Paul A; Shea, Meghan; Le, Xiuning; Huberman, Mark S; Kobayashi, Susumu S; Costa, Daniel B

发表日期：2017

文献求助收藏

Pulse Afatinib for ERBB2 Exon 20 Insertion-Mutated Lung Adenocarcinomas

脉冲式阿法替尼治疗ERBB2外显子20插入突变型肺腺癌

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1016/j.jtho.2016.02.016

Costa, Daniel B; Jorge, Susan E; Moran, Jason P; Freed, Jason A; Zerillo, Jessica A; Huberman, Mark S; Kobayashi, Susumu S

发表日期：2016

文献求助收藏

Lazarus-Type Response to Crizotinib in a Patient with Poor Performance Status and Advanced MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma

克唑替尼治疗一名体能状态差且MET 14号外显子跳跃突变阳性的晚期肺腺癌患者，产生了拉扎勒斯型反应

期刊:Journal of Thoracic Oncology

影响因子:20.8

doi:10.1016/j.jtho.2016.01.017

Shea, Meghan; Huberman, Mark S; Costa, Daniel B

发表日期：2016

文献求助收藏

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers

EGFR突变或ALK重排的非小细胞肺癌患者的脑转移

期刊:Lung Cancer

影响因子:4.4

doi:10.1016/j.lungcan.2015.01.020

Rangachari, Deepa; Yamaguchi, Norihiro; VanderLaan, Paul A; Folch, Erik; Mahadevan, Anand; Floyd, Scott R; Uhlmann, Erik J; Wong, Eric T; Dahlberg, Suzanne E; Huberman, Mark S; Costa, Daniel B

细胞生物学

发表日期：2015

文献求助收藏

Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling

通过全面基因组分析检测具有MET、ALK和ROS1基因组改变的克唑替尼敏感肺腺癌

期刊:Clinical Lung Cancer

影响因子:3.3

doi:10.1016/j.cllc.2015.03.002

Le, Xiuning; Freed, Jason A; VanderLaan, Paul A; Huberman, Mark S; Rangachari, Deepa; Jorge, Susan E; Lucena-Araujo, Antonio R; Kobayashi, Susumu S; Balasubramanian, Sohail; He, Jie; Chudnovsky, Yakov; Miller, Vincent A; Ali, Siraj M; Costa, Daniel B

发表日期：2015

文献求助收藏